Welcome to LookChem.com Sign In|Join Free

CAS

  • or

100644-65-3

Post Buying Request

100644-65-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

100644-65-3 Usage

General Description

4-CHLORO-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE is a chemical compound with the molecular formula C6H5ClN6. It is a chlorinated derivative of pyrazolo[3,4-d]pyrimidin-6-amine, which is used as a building block in the synthesis of various pharmaceutical compounds. This chemical is often used as an intermediate in the production of drugs or agrochemicals due to its versatile reactivity and ability to undergo various functional group transformations. Additionally, it is known for its potential as a kinase inhibitor, which makes it a valuable compound for research and development in the pharmaceutical industry. Overall, 4-CHLORO-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE has a wide range of applications in the field of medicinal chemistry and drug discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 100644-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,6,4 and 4 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 100644-65:
(8*1)+(7*0)+(6*0)+(5*6)+(4*4)+(3*4)+(2*6)+(1*5)=83
83 % 10 = 3
So 100644-65-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H4ClN5/c6-3-2-1-8-11-4(2)10-5(7)9-3/h1H,(H3,7,8,9,10,11)

100644-65-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloro-1H-pyrazolo[3,4-d]pyrimidin-6-amine

1.2 Other means of identification

Product number -
Other names 4-CHLORO-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-AMINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100644-65-3 SDS

100644-65-3Relevant articles and documents

Impact of Minor Structural Modifications on Properties of a Series of mTOR Inhibitors

Ouvry, Gilles,Clary, Laurence,Tomas, Lo?c,Aurelly, Michèle,Bonnary, Laetitia,Borde, Emilie,Bouix-Peter, Claire,Chantalat, Laurent,Defoin-Platel, Claire,Deret, Sophie,Forissier, Mathieu,Harris, Craig S.,Isabet, Tatiana,Lamy, Laurent,Luzy, Anne-Pascale,Pascau, Jonathan,Soulet, Catherine,Taddei, Alessandro,Taquet, Nathalie,Thoreau, Etienne,Varvier, Emeric,Vial, Emmanuel,Hennequin, Laurent F.

, p. 1561 - 1567 (2019)

Minor structural modifications - sometimes single atom changes - can have a dramatic impact on the properties of compounds. This is illustrated here on structures related to known mTOR inhibitor Sapanisertib. Subtle changes in the hinge binder lead to strikingly different overall profiles with changes in physical properties, metabolism, and kinase selectivity.

ADENOSINE RECEPTOR ANTAGONIST COMPOUNDS

-

Paragraph 00339-00342, (2021/05/29)

The present disclosure provides adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of cancer and in immuno-oncology. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson's disease.

Fused pyrimidine derivatives substituted with a nitrogen-containing heterocyclic ring and their pharmaceutical use

-

Paragraph 0191-0196, (2021/07/17)

The present application relates to fused pyrimidine derivatives substituted with heterocycles containing nitrogen and to their medicinal use. Provided are a compound represented by chemical formula I, a solvate, a stereoisomer thereof, a pharmaceutically

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100644-65-3